Which has better valuation and earnings, GH or NTRA?

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 17.67 -$416.28M -$3.39 N/A Natera $2.31B 14.58 -$208.16M -$1.63 N/A

Is GH or NTRA more profitable?

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Guardant Health -40.10% N/A -26.42% Natera -9.05% -14.74% -10.27%

Does the media prefer GH or NTRA?

In the previous week, Natera had 3 more articles in the media than Guardant Health. MarketBeat recorded 11 mentions for Natera and 8 mentions for Guardant Health. Natera's average media sentiment score of 0.99 beat Guardant Health's score of 0.10 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Natera 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to BTSG or GH?

In the previous week, Guardant Health had 5 more articles in the media than BrightSpring Health Services. MarketBeat recorded 8 mentions for Guardant Health and 3 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.88 beat Guardant Health's score of 0.10 indicating that BrightSpring Health Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media prefer FMS or GH?

In the previous week, Guardant Health had 6 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 8 mentions for Guardant Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.85 beat Guardant Health's score of 0.10 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media prefer GH or HIMS?

In the previous week, Hims & Hers Health had 16 more articles in the media than Guardant Health. MarketBeat recorded 24 mentions for Hims & Hers Health and 8 mentions for Guardant Health. Hims & Hers Health's average media sentiment score of 0.55 beat Guardant Health's score of 0.10 indicating that Hims & Hers Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Hims & Hers Health 11 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, PACS or GH?

PACS Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PACS Group $5.29B 1.12 $191.54M $1.56 23.90 Guardant Health $982.02M 17.67 -$416.28M -$3.39 N/A

Does the media refer more to PACS or GH?

In the previous week, PACS Group had 2 more articles in the media than Guardant Health. MarketBeat recorded 10 mentions for PACS Group and 8 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.10 beat PACS Group's score of -0.05 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Guardant Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Guardant Health (GH) Competitors

$130.83 +2.00 (+1.55%)

Closing price 06/23/2026 04:00 PM Eastern

Extended Trading

$131.99 +1.16 (+0.89%)

As of 04:38 AM Eastern

Compare

GH vs. NTRA, BTSG, FMS, HIMS, and PACS

Should you buy Guardant Health stock or one of its competitors? MarketBeat compares Guardant Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Guardant Health include Natera (NTRA), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does Guardant Health compare to Natera?

Guardant Health (NASDAQ:GH) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment.

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	17.67	-$416.28M	-$3.39	N/A
Natera	$2.31B	14.58	-$208.16M	-$1.63	N/A

Guardant Health presently has a consensus target price of $141.95, indicating a potential upside of 8.50%. Natera has a consensus target price of $257.71, indicating a potential upside of 9.77%. Given Natera's higher probable upside, analysts plainly believe Natera is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	21 Buy rating(s)	1 Strong Buy rating(s)	2.96
Natera	1 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.81

Guardant Health has a beta of 1.61, meaning that its share price is 61% more volatile than the broader market. Comparatively, Natera has a beta of 1.56, meaning that its share price is 56% more volatile than the broader market.

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 5.6% of Guardant Health shares are held by company insiders. Comparatively, 5.1% of Natera shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Natera	-9.05%	-14.74%	-10.27%

In the previous week, Natera had 3 more articles in the media than Guardant Health. MarketBeat recorded 11 mentions for Natera and 8 mentions for Guardant Health. Natera's average media sentiment score of 0.99 beat Guardant Health's score of 0.10 indicating that Natera is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Natera	5 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Natera beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does Guardant Health compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Guardant Health (NASDAQ:GH) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.

BrightSpring Health Services has a net margin of 2.27% compared to Guardant Health's net margin of -40.10%. BrightSpring Health Services' return on equity of 14.63% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
Guardant Health	-40.10%	N/A	-26.42%

In the previous week, Guardant Health had 5 more articles in the media than BrightSpring Health Services. MarketBeat recorded 8 mentions for Guardant Health and 3 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.88 beat Guardant Health's score of 0.10 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

BrightSpring Health Services currently has a consensus target price of $61.27, suggesting a potential downside of 8.34%. Guardant Health has a consensus target price of $141.95, suggesting a potential upside of 8.50%. Given Guardant Health's higher probable upside, analysts clearly believe Guardant Health is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	2 Strong Buy rating(s)	3.11
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	21 Buy rating(s)	1 Strong Buy rating(s)	2.96

BrightSpring Health Services has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	1.02	$190.67M	$1.41	47.40
Guardant Health	$982.02M	17.67	-$416.28M	-$3.39	N/A

92.6% of Guardant Health shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by insiders. Comparatively, 5.6% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

BrightSpring Health Services has a beta of 1.87, suggesting that its share price is 87% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.61, suggesting that its share price is 61% more volatile than the broader market.

Summary

BrightSpring Health Services beats Guardant Health on 11 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Guardant Health (NASDAQ:GH) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $28.00, suggesting a potential upside of 17.99%. Guardant Health has a consensus price target of $141.95, suggesting a potential upside of 8.50%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, equities research analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	21 Buy rating(s)	1 Strong Buy rating(s)	2.96

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Guardant Health's net margin of -40.10%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%
Guardant Health	-40.10%	N/A	-26.42%

In the previous week, Guardant Health had 6 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 8 mentions for Guardant Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.85 beat Guardant Health's score of 0.10 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market. Comparatively, Guardant Health has a beta of 1.61, suggesting that its stock price is 61% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.58	$1.11B	$1.90	12.49
Guardant Health	$982.02M	17.67	-$416.28M	-$3.39	N/A

Summary

Fresenius Medical Care AG & Co. KGaA beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Hims & Hers Health?

Guardant Health (NASDAQ:GH) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

Guardant Health currently has a consensus price target of $141.95, suggesting a potential upside of 8.50%. Hims & Hers Health has a consensus price target of $29.37, suggesting a potential downside of 11.01%. Given Guardant Health's stronger consensus rating and higher probable upside, analysts clearly believe Guardant Health is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	21 Buy rating(s)	1 Strong Buy rating(s)	2.96
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Guardant Health has a beta of 1.61, suggesting that its share price is 61% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, suggesting that its share price is 137% more volatile than the broader market.

Hims & Hers Health has a net margin of -0.56% compared to Guardant Health's net margin of -40.10%. Hims & Hers Health's return on equity of 6.10% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Hims & Hers Health	-0.56%	6.10%	1.52%

In the previous week, Hims & Hers Health had 16 more articles in the media than Guardant Health. MarketBeat recorded 24 mentions for Hims & Hers Health and 8 mentions for Guardant Health. Hims & Hers Health's average media sentiment score of 0.55 beat Guardant Health's score of 0.10 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Hims & Hers Health	11 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health has higher revenue and earnings than Guardant Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	17.67	-$416.28M	-$3.39	N/A
Hims & Hers Health	$2.37B	3.22	$128.37M	-$0.09	N/A

Summary

Hims & Hers Health beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does Guardant Health compare to PACS Group?

PACS Group (NYSE:PACS) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations, profitability and media sentiment.

PACS Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.12	$191.54M	$1.56	23.90
Guardant Health	$982.02M	17.67	-$416.28M	-$3.39	N/A

92.6% of Guardant Health shares are held by institutional investors. 70.1% of PACS Group shares are held by company insiders. Comparatively, 5.6% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, PACS Group had 2 more articles in the media than Guardant Health. MarketBeat recorded 10 mentions for PACS Group and 8 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.10 beat PACS Group's score of -0.05 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Guardant Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

PACS Group has a net margin of 4.49% compared to Guardant Health's net margin of -40.10%. PACS Group's return on equity of 26.47% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Guardant Health	-40.10%	N/A	-26.42%

PACS Group currently has a consensus target price of $48.00, suggesting a potential upside of 28.72%. Guardant Health has a consensus target price of $141.95, suggesting a potential upside of 8.50%. Given PACS Group's higher possible upside, analysts clearly believe PACS Group is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	21 Buy rating(s)	1 Strong Buy rating(s)	2.96

Summary

PACS Group beats Guardant Health on 10 of the 16 factors compared between the two stocks.

Get Guardant Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GH vs. The Competition

Export

Metric	Guardant Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$17.08B	$3.45B	$6.44B	$12.38B
Dividend Yield	N/A	2.30%	2.69%	5.83%
P/E Ratio	-38.59	19.75	24.67	23.99
Price / Sales	17.67	330.65	528.41	106.93
Price / Cash	N/A	128.56	44.82	54.51
Price / Book	-165.61	8.29	10.76	6.50
Net Income	-$416.28M	$23.85M	$3.56B	$336.88M
7 Day Performance	1.33%	2.87%	1.03%	-0.14%
1 Month Performance	9.99%	2.19%	0.45%	0.77%
1 Year Performance	161.71%	55.48%	29.69%	28.49%

Guardant Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GH Guardant Health	2.191 of 5 stars	$130.83 +1.6%	$141.95 +8.5%	+169.5%	$17.08B	$982.02M	N/A	2,506	Insider Trade
NTRA Natera	3.4106 of 5 stars	$228.80 -1.1%	$256.53 +12.1%	+37.8%	$33.14B	$2.31B	N/A	6,140	Analyst Forecast
BTSG BrightSpring Health Services	4.0757 of 5 stars	$67.20 +1.4%	$61.27 -8.8%	+193.5%	$13.07B	$12.91B	47.66	23,500	Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	4.3857 of 5 stars	$23.40 -0.8%	$28.00 +19.7%	-12.6%	$12.74B	$22.20B	12.31	1,488	News Coverage
HIMS Hims & Hers Health	3.0864 of 5 stars	$33.60 -5.3%	$29.37 -12.6%	-21.6%	$8.21B	$2.35B	N/A	2,442	Trending News Insider Trade Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GH) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Guardant Health (GH) Competitors

GH vs. NTRA, BTSG, FMS, HIMS, and PACS

How does Guardant Health compare to Natera?

Summary

How does Guardant Health compare to BrightSpring Health Services?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Guardant Health compare to Hims & Hers Health?

Summary

How does Guardant Health compare to PACS Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Guardant Health (GH) Competitors

GH vs. NTRA, BTSG, FMS, HIMS, and PACS

How does Guardant Health compare to Natera?

Which has better valuation and earnings, GH or NTRA?

Do analysts prefer GH or NTRA?

Which has more risk & volatility, GH or NTRA?

Do insiders and institutionals believe in GH or NTRA?

Is GH or NTRA more profitable?

Does the media prefer GH or NTRA?

Summary

How does Guardant Health compare to BrightSpring Health Services?

Is BTSG or GH more profitable?

Does the media refer more to BTSG or GH?

Do analysts prefer BTSG or GH?

Which has better earnings and valuation, BTSG or GH?

Do institutionals and insiders have more ownership in BTSG or GH?

Which has more volatility and risk, BTSG or GH?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Do analysts prefer FMS or GH?

Do institutionals & insiders have more ownership in FMS or GH?

Is FMS or GH more profitable?

Does the media prefer FMS or GH?

Which has more risk & volatility, FMS or GH?

Which has higher valuation and earnings, FMS or GH?

Summary

How does Guardant Health compare to Hims & Hers Health?

Do analysts prefer GH or HIMS?

Do insiders and institutionals have more ownership in GH or HIMS?

Which has more volatility and risk, GH or HIMS?

Is GH or HIMS more profitable?

Does the media prefer GH or HIMS?

Which has better valuation & earnings, GH or HIMS?

Summary

How does Guardant Health compare to PACS Group?

Which has better earnings and valuation, PACS or GH?

Do insiders & institutionals hold more shares of PACS or GH?

Does the media refer more to PACS or GH?

Is PACS or GH more profitable?

Do analysts recommend PACS or GH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools